What is the purpose of this trial?
The purpose of this study is to evaluate the efficacy and safety of pevonedistat plus azacitidine versus single-agent azacitidine in participants with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia and low-blast acute myelogenous leukemia.
Dates: 02/10/2017 - 12/01/2017
Last Updated: 03/02/2017
Study HIC#: 1603017438